Currently out of the existing stock ratings of Brandon Couillard, 132 are a BUY (71.74%), 46 are a HOLD (25%), 6 are a SELL (3.26%).

Brandon Couillard

Work Performance Price Targets & Ratings Chart

Analyst Brandon Couillard, currently employed at WELLS FARGO, carries an average stock price target met ratio of 70.2% that have a potential upside of 17% achieved within 157 days. Previously, Brandon Couillard worked at JEFFERIES.

Brandon Couillard’s has documented 384 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Basic Materials, Technology, Industrials sectors.

Most recent stock forecast was given on A, Agilent Technologies at 25-Nov-2025.

Wall Street Analyst Brandon Couillard

Analyst best performing recommendations are on CDNA (CAREDX).
The best stock recommendation documented was for MYGN (MYRIAD GENETICS) at 2/25/2025. The price target of $11 was fulfilled within 3 days with a profit of $0.74 (6.3%) receiving and performance score of 21.01.

Average potential price target upside

of $111.29 (7.97%) on MTD (METTLER-TOLEDO INTERNATIONAL).
of $72.14 (19.22%) on TMO (THERMO FISHER SCIENTIFIC).
of $67.43 (22.34%) on BIO (BIO-RAD LABORATORIES).

A Agilent Technologies ALGN Align Technology AVTR Avantor BIO Bio-Rad Laboratories EXAS EXACT Sciences KEYS Keysight Technologies MYGN Myriad Genetics DHR Danaher WAT Waters BRKR Bruker CDXS Codexis OSUR OraSure Technologies RGEN Repligen ONVO Organovo Holdings SMFR Sema4 Holdings Corp OPK Opko Health TMO Thermo Fisher Scientific CYRX Cryoport SDC SmileDirectClub SLGC Somalogic MRVI Maravai Lifesciences Holdings CDNA Caredx MTD Mettler-Toledo International PDCO Patterson Companies XRAY Dentsply Sirona GHDX Genomic Health LMNX Luminex QTNT Quotient Ltd MLAB Mesa Laboratories

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Brandon Couillard (WELLS FARGO)